Hepatitis B Vaccine in Patients With Inflammatory Bowel Disease

NACompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2016

Conditions
Inflammatory Bowel Disease
Interventions
BIOLOGICAL

ENGERIX-B (HBV Vaccine)

ENGERIX-B (Hepatitis B Vaccine) 20 mcg, A series of 3 doses (1 mL each) given on a 0-, 1-, 6-month schedule.

BIOLOGICAL

Sci-B-Vac

Sci-B-Vac (Hepatitis B Vaccine) 10 μg/ml, A series of 3 doses (1 mL each) given on a 0-, 1-, 6-month schedule.

Trial Locations (1)

84101

Soroka UMC, Beersheba

All Listed Sponsors
lead

Soroka University Medical Center

OTHER

NCT01531075 - Hepatitis B Vaccine in Patients With Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter